Posted: Thursday, December 16, 2021
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary
Posted: Friday, December 10, 2021
Category - Medicines Update
Ronapreve® is now indicated in two distinct patient populations:
Group 1: Patients admitted unwell with COVID-19 who are negative for baseline serum anti-spike (anti-S) antibodies against SARS-CoV-2.
Group 2: Patients with early hospital onset COVID-19 who are at high risk of progression to severe COVID-19 or in whom COVID-19 infection presents a material risk of destabilising a pre-existing condition or illness or compromising recovery from surgery or other hospital procedure.
Posted: Wednesday, December 8, 2021
Category - Medicines Update
Guideline News for November 2021
Posted: Wednesday, December 1, 2021
Category - Medicines Update
Antiretrovirals for the treatment of HIV in Acute.
Posted: Wednesday, December 1, 2021
Category - Medicines Update
Key Medicine Shortages for November 2021
Posted: Wednesday, December 1, 2021
Category - Medicines Update
Many liquid medicines have multiple concentrations; this applies to licensed and unlicensed preparations. Switching between concentrations is a known cause of dosing error.
Posted: Friday, November 26, 2021
Category - Formulary Update
Posted: Wednesday, November 24, 2021
Category - Medicines Update
New clinical guideline - Proton Pump Inhibitor Guideline for Neonates and Paediatrics. The guideline contains information on preferred choice of PPI, as well as dosage and administration advice.
Posted: Tuesday, November 9, 2021
Category - Medicines Update
The carbon footprint of inhalers was considered during the recent review of the NHSGGC COPD and adult asthma inhaler device guides (IDGs) (available on StaffNet). The IDGs now have a traffic light key which highlights if the inhaler has a very high, high or low carbon footprint.
Posted: Monday, November 8, 2021
Category - Medicines Update
Guideline News for October 2021